Skip to main content
Log in

The pharmacokinetics of midazolam in man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Midazolam, a new water-soluble benzodiazepine, was administered as: i) 5 mg intravenously, ii) a 10-mg oral solution and iii) a 10-mg oral tablet, to six volunteers whose informed consent had been obtained. Midazolam plasma concentrations were measured using an electron-capture gas-liquid chromatographic assay. After 5-mg intravenous midazolam, subjects fell asleep within 1–2 min and continued to sleep for an average of 1.33 h. After oral midazolam intake (solution or tablets), drowsiness appeared after a average of 0.38 h (range 0.25–0.55 h) and sleep continued for an average of 1.17 h. The time to reach peak plasma midazolam concentration after the 10-mg solution dose (0.37±0.45 h) did not differe significantly (‘t’=2.04, df=10,p>0.05) from the time to reach peak plasma midazolam level after the 10-mg tablet dose (0.74±0.45 h). The terminal half-life, (t1/2), of midazolam in plasma was 1.77±0.83 h and there was no significant difference between the mean terminal half-life values obtained for the three midazolam formulations. The mean total clearance (Cl), of midazolam after 5-mg intravenous administration was 0.383±0.094 l·kg−1·h−1. The first pass effect, F, determined experimentally (0.36±0.09) indicated the substantial first pass metabolism of midazolam. The percentage of the midazolam dose excreted unchanged in urine in four subjects during the 0-8-h urine collection interval was very small (0.011%–0.028%).

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Archer GA, Sternbach LH (1968) The chemistry of benzodiazepines. Chem Rev 68: 747–784

    Google Scholar 

  • Gibaldi M, Perrier D (1975) In: Pharmacokinetics, vol. 1. J. Swarbrick (ed) Drugs and the pharmaceutical sciences. Marcel Dekker, New York, pp 293–296

    Google Scholar 

  • Puglisi CV, Meyer JC, D'Arconte L, Brooks MA, de Silva JAF (1978) Determination of water soluble imidazo-1,4-benzodiazepines in blood by electroncapture gas-liquid chromatography and in urine by differential pulse polarography. J Chromatogr 145: 81–96

    Google Scholar 

  • Reeves JG, Corssen G, Holcomb C (1978) Comparison of two benzodiazepines for anaesthesia induction: midazolam and diazepam. Can Anaesth Soc J 25: 211–214

    Google Scholar 

  • Sedman AJ, Wagner JG (1976) CSTRIP, a fortran IV computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 65: 1006

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Smith, M.T., Eadie, M.J. & Brophy, T.O. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 19, 271–278 (1981). https://doi.org/10.1007/BF00562804

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00562804

Key words

Navigation